NatureCell Co.,Ltd. (KOSDAQ: A007390)
Health Care · Biotechnology · KR
₩24,550.00
-0.81% today · +22.1% 1Y
NatureCell Co.,Ltd. (KOSDAQ: A007390) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.18B.
Over the last twelve months the share price has gained 22.1%, trading between 16.55K and 36.95K.
Tweenvest scores NatureCell Co.,Ltd. across four factors: quality 75/100, value 56/100. Its strongest factor is quality.
A007390 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.18B
- Revenue (TTM)
- $13.24M
- P/E
- —
- EPS
- -42.06
- Dividend yield
- —
- Beta (5Y)
- 0.68
- 52-week high
- ₩36,950.00
- 52-week low
- ₩16,550.00
- Avg volume (3M)
- —
- Shares outstanding
- 64.44M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nanobiotix S.A.ENXTPA: NANO | $1.21B | €21.24 | +3.51% |
| Bio-Thera Solutions, Ltd.SHSE: 688177 | $1.19B | CN¥19.30 | -8.23% |
| BioGaia AB (publ)OM: BIOG B | $1.18B | Skr116.80 | +1.21% |
| Vor Biopharma Inc.NasdaqGS: VOR | $1.18B | $19.89 | -0.05% |
| HBM Holdings LimitedSEHK: 2142 | $1.17B | HK$11.14 | -17.11% |
| Aimed Bio Inc.KOSDAQ: A0009K0 | $1.17B | ₩24,250.00 | -2.22% |
| Bicara Therapeutics Inc.NasdaqGM: BCAX | $1.16B | $17.25 | -1.43% |
| Amoy Diagnostics Co., Ltd.SZSE: 300685 | $1.16B | CN¥20.30 | -4.87% |
Figures last refreshed Oct 11, 2026.